An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells

Jae Hyung Jang, James T. Koerber, Jung Suk Kim, Prashanth Asuri, Tandis Vazin, Melissa Bartel, Albert Keung, Inchan Kwon, Kook In Park, David V. Schaffer

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Gene delivery to, and gene targeting in, stem cells would be a highly enabling technology for basic science and biomedical application. Adeno-associated viral (AAV) vectors have demonstrated the capacity for efficient delivery to numerous cells, but their application to stem cells has been limited by low transduction efficiency. Due to their considerable advantages, however, engineering AAV delivery systems to enhance gene delivery to stem cells may have an impact in stem cell biology and therapy. Therefore, using several diverse AAV capsid librariesincluding randomly mutagenized, DNA shuffled, and random peptide insertion variantswe applied directed evolution to create a designer AAV vector with enhanced delivery efficiency for neural stem cells (NSCs). A novel AAV variant, carrying an insertion of a selected peptide sequence on the surface of the threefold spike within the heparin-binding site, emerged from this evolution. Importantly, this evolved AAV variant mediated efficient gene delivery to rat, mouse, and human NSCs, as well as efficient gene targeting within adult NSCs, and it is thus promising for applications ranging from basic stem cell biology to clinical translation.

Original languageEnglish
Pages (from-to)667-675
Number of pages9
JournalMolecular Therapy
Volume19
Issue number4
DOIs
Publication statusPublished - 2011 Apr

Fingerprint

Neural Stem Cells
Gene Targeting
Stem Cells
Genes
Cell Biology
Peptides
Adult Stem Cells
Capsid
Cell- and Tissue-Based Therapy
Heparin
Binding Sites
Technology
DNA

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Cite this

Jang, J. H., Koerber, J. T., Kim, J. S., Asuri, P., Vazin, T., Bartel, M., ... Schaffer, D. V. (2011). An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells. Molecular Therapy, 19(4), 667-675. https://doi.org/10.1038/mt.2010.287
Jang, Jae Hyung ; Koerber, James T. ; Kim, Jung Suk ; Asuri, Prashanth ; Vazin, Tandis ; Bartel, Melissa ; Keung, Albert ; Kwon, Inchan ; Park, Kook In ; Schaffer, David V. / An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells. In: Molecular Therapy. 2011 ; Vol. 19, No. 4. pp. 667-675.
@article{c1f770db3f334d3ca67ce32049f1b55f,
title = "An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells",
abstract = "Gene delivery to, and gene targeting in, stem cells would be a highly enabling technology for basic science and biomedical application. Adeno-associated viral (AAV) vectors have demonstrated the capacity for efficient delivery to numerous cells, but their application to stem cells has been limited by low transduction efficiency. Due to their considerable advantages, however, engineering AAV delivery systems to enhance gene delivery to stem cells may have an impact in stem cell biology and therapy. Therefore, using several diverse AAV capsid librariesincluding randomly mutagenized, DNA shuffled, and random peptide insertion variantswe applied directed evolution to create a designer AAV vector with enhanced delivery efficiency for neural stem cells (NSCs). A novel AAV variant, carrying an insertion of a selected peptide sequence on the surface of the threefold spike within the heparin-binding site, emerged from this evolution. Importantly, this evolved AAV variant mediated efficient gene delivery to rat, mouse, and human NSCs, as well as efficient gene targeting within adult NSCs, and it is thus promising for applications ranging from basic stem cell biology to clinical translation.",
author = "Jang, {Jae Hyung} and Koerber, {James T.} and Kim, {Jung Suk} and Prashanth Asuri and Tandis Vazin and Melissa Bartel and Albert Keung and Inchan Kwon and Park, {Kook In} and Schaffer, {David V.}",
year = "2011",
month = "4",
doi = "10.1038/mt.2010.287",
language = "English",
volume = "19",
pages = "667--675",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "4",

}

Jang, JH, Koerber, JT, Kim, JS, Asuri, P, Vazin, T, Bartel, M, Keung, A, Kwon, I, Park, KI & Schaffer, DV 2011, 'An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells', Molecular Therapy, vol. 19, no. 4, pp. 667-675. https://doi.org/10.1038/mt.2010.287

An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells. / Jang, Jae Hyung; Koerber, James T.; Kim, Jung Suk; Asuri, Prashanth; Vazin, Tandis; Bartel, Melissa; Keung, Albert; Kwon, Inchan; Park, Kook In; Schaffer, David V.

In: Molecular Therapy, Vol. 19, No. 4, 04.2011, p. 667-675.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells

AU - Jang, Jae Hyung

AU - Koerber, James T.

AU - Kim, Jung Suk

AU - Asuri, Prashanth

AU - Vazin, Tandis

AU - Bartel, Melissa

AU - Keung, Albert

AU - Kwon, Inchan

AU - Park, Kook In

AU - Schaffer, David V.

PY - 2011/4

Y1 - 2011/4

N2 - Gene delivery to, and gene targeting in, stem cells would be a highly enabling technology for basic science and biomedical application. Adeno-associated viral (AAV) vectors have demonstrated the capacity for efficient delivery to numerous cells, but their application to stem cells has been limited by low transduction efficiency. Due to their considerable advantages, however, engineering AAV delivery systems to enhance gene delivery to stem cells may have an impact in stem cell biology and therapy. Therefore, using several diverse AAV capsid librariesincluding randomly mutagenized, DNA shuffled, and random peptide insertion variantswe applied directed evolution to create a designer AAV vector with enhanced delivery efficiency for neural stem cells (NSCs). A novel AAV variant, carrying an insertion of a selected peptide sequence on the surface of the threefold spike within the heparin-binding site, emerged from this evolution. Importantly, this evolved AAV variant mediated efficient gene delivery to rat, mouse, and human NSCs, as well as efficient gene targeting within adult NSCs, and it is thus promising for applications ranging from basic stem cell biology to clinical translation.

AB - Gene delivery to, and gene targeting in, stem cells would be a highly enabling technology for basic science and biomedical application. Adeno-associated viral (AAV) vectors have demonstrated the capacity for efficient delivery to numerous cells, but their application to stem cells has been limited by low transduction efficiency. Due to their considerable advantages, however, engineering AAV delivery systems to enhance gene delivery to stem cells may have an impact in stem cell biology and therapy. Therefore, using several diverse AAV capsid librariesincluding randomly mutagenized, DNA shuffled, and random peptide insertion variantswe applied directed evolution to create a designer AAV vector with enhanced delivery efficiency for neural stem cells (NSCs). A novel AAV variant, carrying an insertion of a selected peptide sequence on the surface of the threefold spike within the heparin-binding site, emerged from this evolution. Importantly, this evolved AAV variant mediated efficient gene delivery to rat, mouse, and human NSCs, as well as efficient gene targeting within adult NSCs, and it is thus promising for applications ranging from basic stem cell biology to clinical translation.

UR - http://www.scopus.com/inward/record.url?scp=79953325690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953325690&partnerID=8YFLogxK

U2 - 10.1038/mt.2010.287

DO - 10.1038/mt.2010.287

M3 - Article

C2 - 21224831

AN - SCOPUS:79953325690

VL - 19

SP - 667

EP - 675

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 4

ER -